COV — CLEO Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for CLEO Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.043	0.24	9.37	6.46	6.22
Net Total Accounts Receivable
Net Total Receivables	0.001	0.032	0.057	0.071	0.11
Prepaid Expenses
Total Current Assets	0.044	0.58	9.44	6.55	6.34
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.038	0.032	0.033	0.028
Net Intangible Assets
Total Assets	0.244	1.08	9.88	6.94	6.68
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.286	2.02	0.486	1.1	1.67
Total Long Term Debt
Total Debt
Total Liabilities	0.286	2.02	0.486	1.1	1.67
Common Stock
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-0.042	-0.943	9.39	5.83	5.01
Total Liabilities & Shareholders' Equity	0.244	1.08	9.88	6.94	6.68
Total Common Shares Outstanding